Abstract

Simple SummaryThe overuse and misuse of antimicrobials in dairy farming may lead to the development of antimicrobial resistance and thus to the reduction of the antimicrobial treatment efficacy against animal or human bacterial diseases. This study aims to investigate antimicrobial use differences in four farm groups: mountain farms with specialized high-yield dairy breeds or with dual-purpose breeds raised for milk production, and lowland farms with specialized high-yield dairy breeds or with dual-purpose breeds raised for milk production. From the results, we found a significant difference between mountain farms with dual-purpose breeds and lowland farms with specialized breeds for the overall antimicrobial use and for the use of those antimicrobial classes that are most important in human medicine. Mountain farms have a generally lower milk production and smaller herd size than lowland farms, provide cows with access to pasture, and limit concentrates in the diet. These management practices and the use of local/dual-purpose breeds could reduce the risk of production diseases and the consequent need for antimicrobial use.The quantitative assessment of antimicrobial use (AMU) in food-producing animals contributes to the provision of essential information for developing relevant and effective policies to reduce use and to control antimicrobial resistance. Information on AMU is available mainly for intensive dairy farming systems and specialized high-yielding breeds. The aim of this study is to investigate AMU in different dairy farming systems by comparing the treatment incidence in mountain farms with specialized high-yield dairy breeds or with dual-purpose breeds raised for milk production to the treatment incidence in lowland farms with specialized high-yield dairy breeds or with dual-purpose breeds raised for milk production. Significant differences were found only between the overall treatment incidence, as well as the treatment incidence of highest-priority critically important antimicrobials for human medicine, in lowland farms with high-yielding breeds and mountain farms with dual-purpose breeds. Mountain farms have a generally lower milk production and smaller herd size than lowland farms, provide cows with access to pasture, and limit concentrates in the diet. These management practices and the use of local/dual-purpose breeds could reduce the risk of production diseases and the consequent need for AMU.

Highlights

  • Antimicrobial resistance (AMR) is considered a global threat across the human and animal health sectors

  • The aim of this study was to investigate antimicrobial use (AMU) in different dairy farming systems by comparing the treatment incidence in mountain farms with specialized high-yield dairy breeds or with dual-purpose breeds raised for milk production to the treatment incidence in lowland farms with specialized high-yield dairy breeds or with dual-purpose breeds raised for milk production

  • Variables of the same color with different letters (a, b) color with different letters (a, b) differ (p < 0.05). This is the first study looking at differences in AMU across different dairy farming systems using data retrieved from official treatment records

Read more

Summary

Introduction

Antimicrobial resistance (AMR) is considered a global threat across the human and animal health sectors. In order to control the phenomenon, the World Health Organization (WHO) produces and regularly updates a classification and prioritization list of antimicrobials according to their importance for human medicine. The list identifies three main categories: Critically important antimicrobials (CIA), highly important antimicrobials (HIA), and important antimicrobials [1]. Within CIA, two subcategories are identified: Highest-priority. CIA (HP-CIA), which includes cephalosporins of the 3rd, 4th, and 5th generation, glycopeptides, macrolides, ketolides, polymyxins, and quinolones; and high-priority CIA (H-CIA). Resistance against these substances can dramatically limit the treatment options against serious human bacterial diseases and should be prudently used in veterinary medicine.

Objectives
Methods
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.